Literature DB >> 24253041

The conserved Lys-95 charged residue cluster is critical for the homodimerization and enzyme activity of human ribonucleotide reductase small subunit M2.

Xinhuan Chen1, Zhijian Xu, Lingna Zhang, Hongchuan Liu, Xia Liu, Meng Lou, Lijun Zhu, Bingding Huang, Cai-Guang Yang, Weiliang Zhu, Jimin Shao.   

Abstract

Ribonucleotide reductase (RR) catalyzes the reduction of ribonucleotides to deoxyribonucleotides for DNA synthesis. Human RR small subunit M2 exists in a homodimer form. However, the importance of the dimer form to the enzyme and the related mechanism remain unclear. In this study, we tried to identify the interfacial residues that may mediate the assembly of M2 homodimer by computational alanine scanning based on the x-ray crystal structure. Co-immunoprecipitation, size exclusion chromatography, and RR activity assays showed that the K95E mutation in M2 resulted in dimer disassembly and enzyme activity inhibition. In comparison, the charge-exchanging double mutation of K95E and E98K recovered the dimerization and activity. Structural comparisons suggested that a conserved cluster of charged residues, including Lys-95, Glu-98, Glu-105, and Glu-174, at the interface may function as an ionic lock for M2 homodimer. Although the measurements of the radical and iron contents showed that the monomer (the K95E mutant) was capable of generating the diiron and tyrosyl radical cofactor, co-immunoprecipitation and competitive enzyme inhibition assays indicated that the disassembly of M2 dimer reduced its interaction with the large subunit M1. In addition, the immunofluorescent and fusion protein-fluorescent imaging analyses showed that the dissociation of M2 dimer altered its subcellular localization. Finally, the transfection of the wild-type M2 but not the K95E mutant rescued the G1/S phase cell cycle arrest and cell growth inhibition caused by the siRNA knockdown of M2. Thus, the conserved Lys-95 charged residue cluster is critical for human RR M2 homodimerization, which is indispensable to constitute an active holoenzyme and function in cells.

Entities:  

Keywords:  Enzyme Catalysis; Enzyme Mechanisms; Human Ribonucleotide Reductase Small Subunit M2; Protein Crystallization; Protein Structure; Site-directed Mutagenesis

Mesh:

Substances:

Year:  2013        PMID: 24253041      PMCID: PMC3887214          DOI: 10.1074/jbc.M113.524546

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models.

Authors:  P A Kollman; I Massova; C Reyes; B Kuhn; S Huo; L Chong; M Lee; T Lee; Y Duan; W Wang; O Donini; P Cieplak; J Srinivasan; D A Case; T E Cheatham
Journal:  Acc Chem Res       Date:  2000-12       Impact factor: 22.384

Review 2.  Structure and function of the radical enzyme ribonucleotide reductase.

Authors:  H Eklund; U Uhlin; M Färnegårdh; D T Logan; P Nordlund
Journal:  Prog Biophys Mol Biol       Date:  2001-11       Impact factor: 3.667

3.  Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.

Authors:  Lijun Xue; Bingsen Zhou; Xiyong Liu; Weihua Qiu; Zhongchu Jin; Yun Yen
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

4.  A quantitative model for allosteric control of purine reduction by murine ribonucleotide reductase.

Authors:  C P Scott; O B Kashlan; J D Lear; B S Cooperman
Journal:  Biochemistry       Date:  2001-02-13       Impact factor: 3.162

Review 5.  Radical initiation in the class I ribonucleotide reductase: long-range proton-coupled electron transfer?

Authors:  JoAnne Stubbe; Daniel G Nocera; Cyril S Yee; Michelle C Y Chang
Journal:  Chem Rev       Date:  2003-06       Impact factor: 60.622

6.  A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.

Authors:  H Tanaka; H Arakawa; T Yamaguchi; K Shiraishi; S Fukuda; K Matsui; Y Takei; Y Nakamura
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

7.  Investigation of in vivo roles of the C-terminal tails of the small subunit (ββ') of Saccharomyces cerevisiae ribonucleotide reductase: contribution to cofactor formation and intersubunit association within the active holoenzyme.

Authors:  Yan Zhang; Xiuxiang An; Joanne Stubbe; Mingxia Huang
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

8.  Comprehensive model for allosteric regulation of mammalian ribonucleotide reductase: refinements and consequences.

Authors:  Ossama B Kashlan; Barry S Cooperman
Journal:  Biochemistry       Date:  2003-02-18       Impact factor: 3.162

9.  Cobalt substitution of mouse R2 ribonucleotide reductase as a model for the reactive diferrous state: spectroscopic and structural evidence for a ferromagnetically coupled dinuclear cobalt cluster.

Authors:  Kari R Strand; Solveig Karlsen; K Kristoffer Andersson
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

10.  Mouse ribonucleotide reductase R2 protein: a new target for anaphase-promoting complex-Cdh1-mediated proteolysis.

Authors:  Anna Lena Chabes; Cathie M Pfleger; Marc W Kirschner; Lars Thelander
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

View more
  3 in total

1.  Non-enzymatic action of RRM1 protein upregulates PTEN leading to inhibition of colorectal cancer metastasis.

Authors:  Hongyan Qi; Meng Lou; Yuexia Chen; Xiyong Liu; Naiming Chen; Jianzhen Shan; Zhiqiang Ling; Jing Shen; Lijun Zhu; Yun Yen; Shu Zheng; Jimin Shao
Journal:  Tumour Biol       Date:  2015-02-01

2.  Pterostilbene inhibits hepatocellular carcinoma proliferation and HBV replication by targeting ribonucleotide reductase M2 protein.

Authors:  Rui Wang; Zhijian Xu; Jiaping Tian; Qian Liu; Jingwen Dong; Lijuan Guo; Boning Hai; Xia Liu; Hangping Yao; Zhi Chen; Junjie Xu; Lijun Zhu; Haiyi Chen; Tingjun Hou; Weiliang Zhu; Jimin Shao
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

3.  Identification of Monobenzone as a Novel Potential Anti-Acute Myeloid Leukaemia Agent That Inhibits RNR and Suppresses Tumour Growth in Mouse Xenograft Model.

Authors:  Jingwen Dong; Tingting Zhong; Zhijian Xu; Haiyi Chen; Xianjun Wang; Lili Yang; Zhiyuan Lou; Yuanling Xu; Tingjun Hou; Rongzhen Xu; Weiliang Zhu; Jimin Shao
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.